Relafen 750, containing naproxen sodium, presents a intriguing case from a biochemical perspective. Its mechanism of action involves inhibiting cyclooxygenase (COX) enzymes, specifically COX-2, which produces a decrease of prostaglandin synthesis . This biochemical pathway directly affects inflammation and pain perception, highlighting its role as